TrademarkDir
OLIGOMERIX
LIVE

Serial Number

85886219

Owner

Oligomerix, Inc.

Attorney

Nicole K. McLaughlin

Filing Date

Mar 26, 2013

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

OLIGOMERIX Trademark

Serial Number: 85886219 • Registration: 4760737

OLIGOMERIX is a trademark filed by Oligomerix, Inc. on March 26, 2013. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Oligomerix, Inc. (2 trademarks)

Suite 208
White Plains, NY 10604

Entity Type: 03

Trademark Details

Filing Date

March 26, 2013

Registration Date

June 23, 2015

Published for Opposition

November 11, 2014

Goods & Services

Pharmaceutical products for the treatment of diseases, namely, Alzheimer's disease and other neurodegenerative diseases; reagents for diagnostic purposes and diagnostic media intended for medical purposes, namely, reagents and media intended for tests, namely, tests based on blood biomarkers for identifying patients affected by diseases or those at risk of developing a disease and for identifying patients responding to specific personalized treatments; biological acidic products and preparations for pharmaceutical purposes, namely, pharmaceutical preparations for diagnosing diseases, namely, Alzheimer's disease and other neurodegenerative diseases; chemico-pharmaceutical preparations for diagnosing, preventing and treating diseases, namely, Alzheimer's disease and other neurodegenerative diseases; biopharmaceutical products, namely, reagents, chemical entities and compounds for diagnosing, preventing and treating diseases, namely, Alzheimer's disease and other neurodegenerative diseases; chemical preparations for medical and pharmaceutical purposes, namely, chemicals for diagnosing Alzheimer's disease and other neurodegenerative diseases, especially chemical preparations for diagnosing diseases in the nature of neurodegenerative diseases

Chemical products and compositions intended for medical research, namely, reagents, chemical entities and compounds; chemical preparations for scientific purposes, chemical reagents or products for laboratory analyses for monitoring, analyzing and identifying diagnostic targets and therapeutic products, and for conducting research in connection with pharmaceutical sciences; chemical preparations intended for scientific purposes, namely, for leading research in connection with pharmaceutical sciences

Research and development of pharmaceutical molecules, compounds, inhibitors, antibodies and biological markers for diagnostic purposes and medicines for treating diseases; research and development of new products and preparations for the treatment of Alzheimer's disease and other neurodegenerative diseases; research and development in the field of pharmaceutical drugs; biological research; biotechnological research; technical research in the field of biotechnology; consultancy in the field of biotechnology

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Oct 4, 2025 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Oct 4, 2025 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Oct 4, 2025 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 4, 2025 APRE
TEAS SECTION 8 & 9 RECEIVED
Jun 11, 2025 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jun 23, 2024 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jun 9, 2022 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jun 9, 2022 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 9, 2022 APRE
TEAS SECTION 8 & 15 RECEIVED
Dec 21, 2021 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jun 23, 2020 REM1
REGISTERED-PRINCIPAL REGISTER
Jun 23, 2015 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 19, 2015 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 16, 2015 CNPR
STATEMENT OF USE PROCESSING COMPLETE
May 13, 2015 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 11, 2015 AITU
USE AMENDMENT FILED
Apr 10, 2015 IUAF
TEAS STATEMENT OF USE RECEIVED
Apr 10, 2015 EISU
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 10, 2015 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 10, 2015 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 6, 2015 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 11, 2014 NPUB
PUBLISHED FOR OPPOSITION
Nov 11, 2014 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 22, 2014 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 3, 2014 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 3, 2014 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 18, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 18, 2014 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Sep 11, 2014 ERFR
EX PARTE APPEAL-INSTITUTED
Sep 11, 2014 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Sep 11, 2014 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Sep 11, 2014 EXAF
NOTIFICATION OF FINAL REFUSAL EMAILED
Mar 11, 2014 GNFN
FINAL REFUSAL E-MAILED
Mar 11, 2014 GNFR
FINAL REFUSAL WRITTEN
Mar 11, 2014 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 20, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 20, 2014 CRFA
ASSIGNED TO LIE
Feb 12, 2014 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 5, 2014 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 6, 2013 GNRN
NON-FINAL ACTION E-MAILED
Aug 6, 2013 GNRT
NON-FINAL ACTION WRITTEN
Aug 6, 2013 CNRT
ASSIGNED TO EXAMINER
Jul 8, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 29, 2013 NWOS
NEW APPLICATION ENTERED
Mar 29, 2013 NWAP

Related Trademarks

More from this Owner

OLIGOMERIX

OLIGOMERIX

OLIGOMERIX

OLIGOMERIX